Clinical Trials Logo

Clinical Trial Summary

Musculoskeletal deformities of the foot and abnormal biomechanics can create areas of high pressure over bony prominences on the plantar aspect of the foot and often lead to the formation of calluses and corns. Calluses and corns are reported to be the most prevalent foot conditions affecting peoples' lifestyles due to pain and disability. Redistribution of plantar pressure away from areas of high pressure offloading using felt pads to treat corns and calluses is a common practice in chiropody. A more comprehensive understanding of how rapidly the felt pads compress and become less effective in offloading pressure is needed to design better treatment plans to manage calluses and corns and improve patients' quality of life. The objectives of this study are: 1) develop a guideline which informs, at what duration (number of weeks) the semi compressed felt (SCF) Plantar Metatarsal Pad (PMP) should be replaced to manage plantar forefoot callus; 2) Test the guideline by replacing the SCF padding at the determined time interval. The study will be conducted at the Michener Chiropody Clinic at the Michener Institute of Education at UHN. In order to address patient selection bias, the investigators will be recruiting the first 25-40 participants presenting with forefoot callus who meet the inclusion criteria and consent to participate in the study. An exploratory, descriptive and analytic repeated measures study design will be used to address our research questions. The descriptive approach will provide insight into the nature of change over time in the dependent variables, pain and pressure, and an analytic approach will enable further insight into the relationship between those variables. The quantitative metrics used are average plantar pressure at the callus site, as well as self-reported pain using a Visual-Analog Scale (VAS). Results from the first phase will inform the development of the guideline for pad replacement, which in turn will be tested in the next phase of the study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04336514
Study type Interventional
Source University Health Network, Toronto
Contact Ann Russell, PhD
Phone 416-596-3101
Email arussell@michener.ca
Status Recruiting
Phase N/A
Start date March 6, 2020
Completion date August 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT00239135 - Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel Phase 2
Recruiting NCT06206681 - Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Completed NCT00115154 - Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands Phase 4
Completed NCT00116649 - Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis Phase 4
Recruiting NCT05942794 - Identification of Oral Lesions Through an Autofluorescence System N/A
Withdrawn NCT02851693 - Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection N/A
Withdrawn NCT02813902 - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors Phase 1
Completed NCT00121511 - The Effect of Efudex Treatment on Photoaged Skin N/A
Completed NCT00114023 - 1-Year Follow up to the 1473-IMIQ Study Phase 3
Completed NCT05060237 - Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp Phase 1
Recruiting NCT02737176 - Tobacco Cessation Intervention Study for Oral Diseases N/A
Completed NCT00110682 - Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses Phase 4